Long intergenic non-protein coding RNA 1786 (LINC01786)

Long intergenic non-protein coding RNA 1786 (LINC01786) is a long non-coding RNA (lncRNA) transcript classified as a long intergenic non-coding RNA (lincRNA). It does not encode a protein but may regulate gene expression by interacting with chromatin, transcription factors, or RNA-binding proteins. LINC01786 is differentially expressed in subtypes of kidney and prostate cancer, suggesting a role in tumor biology. While specific functional and drug interaction data for this lincRNA are limited, lincRNAs as a class are known to influence chromatin structure, transcription regulation, and cell-type specific gene network modulation[1][3][5]. LINC01786 is not recognized as a classical pharmacological target such as a receptor, enzyme, or transporter, and no approved therapies are directed specifically at it[1][3]. Its upregulation in certain cancers suggests it could serve as a disease biomarker or a potential investigational target, but there is no current evidence of direct drug-targeting[3].

Other names

RP5-902P8.1001p36.33LINC01786[3]